Eravacycline: The Tetracyclines Strike Back.
CONCLUSIONS: Eravacycline is a new tetracycline antibiotic with a broad spectrum of activity that has demonstrated efficacy in the treatment of cIAIs. Although it has activity against multidrug-resistant organisms, data are limited for other indications.
PMID: 31081341 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Heaney M, Mahoney MV, Gallagher JC Tags: Ann Pharmacother Source Type: research
More News: Acinetobacter | Allergy | Allergy & Immunology | Drugs & Pharmacology | Enterococcus | Internet | MRSA | Multidrug Resistance | Staphylococcus Aureus | Study | Tetracycline